publication . Article . Other literature type . 2018

Proteomic alterations in early stage cervical cancer

Coşkun Güzel; Natalia Govorukhina; G. Bea A. Wisman; Christoph Stingl; Lennard J. M. Dekker; Harry G. Klip; Harry Hollema; Victor Guryev; Peter Horvatovich; Ate G.J. van der Zee; ...
Open Access
  • Published: 01 Apr 2018 Journal: Oncotarget, volume 9, pages 18,128-18,147 (eissn: 1949-2553, Copyright policy)
  • Publisher: Impact Journals, LLC
  • Country: Netherlands
Abstract
// Coskun Guzel 1 , Natalia I. Govorukhina 2 , G. Bea A. Wisman 3 , Christoph Stingl 1 , Lennard J.M. Dekker 1 , Harry G. Klip 3 , Harry Hollema 4 , Victor Guryev 2 , Peter L. Horvatovich 2 , Ate G.J. van der Zee 3 , Rainer Bischoff 2 and Theo M. Luider 1 1 Laboratory of Neuro-Oncology, Clinical and Cancer Proteomics, Department of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam 3015 CN, The Netherlands 2 Department of Analytical Biochemistry, Center for Pharmacy, University of Groningen, Groningen 9713 AV, The Netherlands 3 Department of Gynecologic Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center ...
Subjects
free text keywords: Oncology, Biomarker, LCM, PRM, Research Paper, Gynecologic oncology, Laser capture microdissection, medicine.medical_specialty, medicine, Cervical cancer, medicine.disease, Biomarker (medicine), Internal medicine, Proteomics, Stromal cell, Cervical tissue, business.industry, business, Cancer
Download fromView all 7 versions
NARCIS
Article . 2018
Provider: NARCIS
NARCIS
Article . 2018
Provider: NARCIS
44 references, page 1 of 3

1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, MoradiLakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, et al; Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer. 2013. JAMA Oncol. 2015; 1:505-527.

2. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer journal. 2003; 9:348-359.

3. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012; 380:1840-1850.

4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74-108.

5. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, Neal K, Waugh N, Group T. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer. 2007; 97:133-139.

6. Monsonego J, EUROGIN. HPV infections and cervical cancer prevention. Priorities and new directions. Highlights of EUROGIN 2004 International Expert Meeting, Nice, France, October 21-23, 2004. Gynecol Oncol. 2005; 96:830-839.

7. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003; 89:101-105. [OpenAIRE]

8. Nguyen HH, Broker TR, Chow LT, Alvarez RD, Vu HL, Andrasi J, Brewer LR, Jin G, Mestecky J. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecologic Oncology. 2005; 96:452-461.

9. Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 2017; 170:1164-1174e1166.

10. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevino V, Vazquez-Santillan K, et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014; 506:371-375.

11. Cancer Genome Atlas Research Network; Albert Einstein College of Medicine; Analytical Biological Services; Barretos Cancer Hospital; Baylor College of Medicine; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging; Canada's Michael Smith Genome Sciences Centre; Harvard Medical School; Helen F. Graham Cancer Center & Research Institute at Christiana Care Health Services; HudsonAlpha Institute for Biotechnology; ILSbio, LLC; Indiana University School of Medicine; et al. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017; 543:378-384.

12. Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016; 166:755-765. [OpenAIRE]

13. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, Wang X, Qiao JW, Cao S, Petralia F, Kawaler E, Mundt F, Krug K, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016; 534:55-62.

14. Datta S, Malhotra L, Dickerson R, Chaffee S, Sen CK, Roy S. Laser capture microdissection: Big data from small samples. Histol Histopathol. 2015:11622.

15. Langenkamp E, Kamps JA, Mrug M, Verpoorte E, Niyaz Y, Horvatovich P, Bischoff R, Struijker-Boudier H, Molema G. Innovations in studying in vivo cell behavior and pharmacology in complex tissues-microvascular endothelial cells in the spotlight. Cell Tissue Res. 2013; 354:647-669. [OpenAIRE]

44 references, page 1 of 3
Abstract
// Coskun Guzel 1 , Natalia I. Govorukhina 2 , G. Bea A. Wisman 3 , Christoph Stingl 1 , Lennard J.M. Dekker 1 , Harry G. Klip 3 , Harry Hollema 4 , Victor Guryev 2 , Peter L. Horvatovich 2 , Ate G.J. van der Zee 3 , Rainer Bischoff 2 and Theo M. Luider 1 1 Laboratory of Neuro-Oncology, Clinical and Cancer Proteomics, Department of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam 3015 CN, The Netherlands 2 Department of Analytical Biochemistry, Center for Pharmacy, University of Groningen, Groningen 9713 AV, The Netherlands 3 Department of Gynecologic Oncology, Cancer Research Center Groningen, University of Groningen, University Medical Center ...
Subjects
free text keywords: Oncology, Biomarker, LCM, PRM, Research Paper, Gynecologic oncology, Laser capture microdissection, medicine.medical_specialty, medicine, Cervical cancer, medicine.disease, Biomarker (medicine), Internal medicine, Proteomics, Stromal cell, Cervical tissue, business.industry, business, Cancer
Download fromView all 7 versions
NARCIS
Article . 2018
Provider: NARCIS
NARCIS
Article . 2018
Provider: NARCIS
44 references, page 1 of 3

1. Fitzmaurice C, Dicker D, Pain A, Hamavid H, MoradiLakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, Hamadeh RR, Moore A, Werdecker A, et al; Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer. 2013. JAMA Oncol. 2015; 1:505-527.

2. Franco EL, Schlecht NF, Saslow D. The epidemiology of cervical cancer. Cancer journal. 2003; 9:348-359.

3. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012; 380:1840-1850.

4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74-108.

5. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, Neal K, Waugh N, Group T. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer. 2007; 97:133-139.

6. Monsonego J, EUROGIN. HPV infections and cervical cancer prevention. Priorities and new directions. Highlights of EUROGIN 2004 International Expert Meeting, Nice, France, October 21-23, 2004. Gynecol Oncol. 2005; 96:830-839.

7. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003; 89:101-105. [OpenAIRE]

8. Nguyen HH, Broker TR, Chow LT, Alvarez RD, Vu HL, Andrasi J, Brewer LR, Jin G, Mestecky J. Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecologic Oncology. 2005; 96:452-461.

9. Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 2017; 170:1164-1174e1166.

10. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevino V, Vazquez-Santillan K, et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014; 506:371-375.

11. Cancer Genome Atlas Research Network; Albert Einstein College of Medicine; Analytical Biological Services; Barretos Cancer Hospital; Baylor College of Medicine; Beckman Research Institute of City of Hope; Buck Institute for Research on Aging; Canada's Michael Smith Genome Sciences Centre; Harvard Medical School; Helen F. Graham Cancer Center & Research Institute at Christiana Care Health Services; HudsonAlpha Institute for Biotechnology; ILSbio, LLC; Indiana University School of Medicine; et al. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017; 543:378-384.

12. Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, Zhou JY, Petyuk VA, Chen L, Ray D, Sun S, Yang F, Chen L, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell. 2016; 166:755-765. [OpenAIRE]

13. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, Wang X, Qiao JW, Cao S, Petralia F, Kawaler E, Mundt F, Krug K, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016; 534:55-62.

14. Datta S, Malhotra L, Dickerson R, Chaffee S, Sen CK, Roy S. Laser capture microdissection: Big data from small samples. Histol Histopathol. 2015:11622.

15. Langenkamp E, Kamps JA, Mrug M, Verpoorte E, Niyaz Y, Horvatovich P, Bischoff R, Struijker-Boudier H, Molema G. Innovations in studying in vivo cell behavior and pharmacology in complex tissues-microvascular endothelial cells in the spotlight. Cell Tissue Res. 2013; 354:647-669. [OpenAIRE]

44 references, page 1 of 3
Any information missing or wrong?Report an Issue